PACIFILM

Class [005]
Pharmaceuticals for the treatment of agitation associated with neuropsychiatric conditions, namely, neurodegenerative diseases, alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, and other central nervous system disorders, namely depressive disorders, bipolar disorders, mood disorders, schizophrenia, epilepsy, Alzheimer disease, Parkinson disease, multiple sclerosis, post-traumatic stress disorder, obsessive-compulsive disorder, panic disorder, insomnia, migraines, dementia, vascular cognitive impairment, Huntington's disease, Creutzfeldt-Jakob disease, multiple system atrophy, progressive supranuclear palsy, senile dementia of the Alzheimer type (SDAT), and delirium